Chang Q - Search Results

1

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC.

Chu T, Zhong R, Zhong H, Zhang B, Zhang W, Shi C, Qian J, Zhang Y, Chang Q, Zhang X, Dong Y, Teng J, Gao Z, Qiang H, Nie W, Zhao Y, Han Y, Chen Y, Han B. Chu T, et al. Among authors: chang q. J Thorac Oncol. 2021 Apr;16(4):643-652. doi: 10.1016/j.jtho.2020.11.026. Epub 2021 Jan 29. J Thorac Oncol. 2021. PMID: 33524601 Free article. Clinical Trial.

2

First-line pemetrexed/carboplatin or cisplatin/bevacizumab compared with paclitaxel/carboplatin/bevacizumab in patients with advanced non-squamous non-small cell lung cancer with wild-type driver genes: A real-world study in China.

Chang Q, Zhang Y, Xu J, Zhong R, Qiang H, Zhang B, Han B, Qian J, Chu T. Chang Q, et al. Thorac Cancer. 2019 May;10(5):1043-1050. doi: 10.1111/1759-7714.13025. Epub 2019 Mar 22. Thorac Cancer. 2019. PMID: 30900826 Free PMC article.

3

New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer.

Qiang H, Chang Q, Xu J, Qian J, Zhang Y, Lei Y, Han B, Chu T. Qiang H, et al. Among authors: chang q. J Cancer Res Clin Oncol. 2020 Mar;146(3):631-645. doi: 10.1007/s00432-020-03129-6. Epub 2020 Feb 17. J Cancer Res Clin Oncol. 2020. PMID: 32065262 Review.

4

EGFR Tyrosine Kinase Inhibitor (TKI) Combined With Concurrent or Sequential Chemotherapy for Patients With Advanced Lung Cancer and Gradual Progression After First-Line EGFR-TKI Therapy: A Randomized Controlled Study.

Chang Q, Xu J, Qiang H, Teng J, Qian J, Lv M, Zhang Y, Lou Y, Zhao Y, Zhong R, Han B, Chu T. Chang Q, et al. Clin Lung Cancer. 2021 May;22(3):e395-e404. doi: 10.1016/j.cllc.2020.06.005. Epub 2020 Jul 6. Clin Lung Cancer. 2021. PMID: 32747190 Clinical Trial.

5

Epidermal Growth Factor Receptor Mutation Status and Response to Tyrosine Kinase Inhibitors in Advanced Chinese Female Lung Squamous Cell Carcinoma: A Retrospective Study.

Chang Q, Qiang H, Qian J, Lei Y, Lu J, Feng H, Zhao Y, Han B, Zhang Y, Chu T. Chang Q, et al. Front Oncol. 2021 Apr 2;11:652560. doi: 10.3389/fonc.2021.652560. eCollection 2021. Front Oncol. 2021. PMID: 33869057 Free PMC article.

6

Mining GEO and TCGA Database for Immune Microenvironment of Lung Squamous Cell Carcinoma Patients With or Without Chemotherapy.

Qiang H, Li J, Chang Q, Shen Y, Qian J, Chu T. Qiang H, et al. Among authors: chang q. Front Oncol. 2022 Feb 8;12:835225. doi: 10.3389/fonc.2022.835225. eCollection 2022. Front Oncol. 2022. PMID: 35211415 Free PMC article.

7

Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study.

Qiang H, Lei Y, Shen Y, Li J, Zhong H, Zhong R, Zhang X, Chang Q, Lu J, Feng H, Zhu Y, Addeo A, Banna GL, Oh IJ, Qian J, Chu T. Qiang H, et al. Among authors: chang q. Transl Lung Cancer Res. 2022 Jan;11(1):87-99. doi: 10.21037/tlcr-21-1033. Transl Lung Cancer Res. 2022. PMID: 35242630 Free PMC article.

8

A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab.

Shen Y, Li J, Qiang H, Lei Y, Chang Q, Zhong R, Stella GM, Gelsomino F, Kim YW, Abed A, Qian J, Chu T. Shen Y, et al. Among authors: chang q. Transl Lung Cancer Res. 2022 Aug;11(8):1619-1630. doi: 10.21037/tlcr-22-493. Transl Lung Cancer Res. 2022. PMID: 36090639 Free PMC article.

9

Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases.

Qiao R, Zhong R, Chang Q, Teng J, Pei J, Han B, Chu T. Qiao R, et al. Among authors: chang q. Oncotarget. 2017 Jun 12;8(45):79469-79479. doi: 10.18632/oncotarget.18446. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108326 Free PMC article.

10

Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced nonsmall-cell lung cancer patients with ALK fusion in China.

Su C, Zhou J, Qiang H, Zhao J, Chang Q, Ji X, Li J, Xie M, Chu T. Su C, et al. Among authors: chang q. Int J Cancer. 2023 Jan 1;152(1):15-23. doi: 10.1002/ijc.34123. Epub 2022 Jun 17. Int J Cancer. 2023. PMID: 35579989 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,428 results

Search Page

Filters